Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
0.4081
-0.0536 (-11.61%)
At close: Jun 5, 2025, 4:00 PM
0.3789
-0.0292 (-7.16%)
Pre-market: Jun 6, 2025, 4:52 AM EDT
Cellectar Biosciences Employees
Cellectar Biosciences had 11 employees as of December 31, 2024. The number of employees decreased by 9 or -45.00% compared to the previous year.
Employees
11
Change (1Y)
-9
Growth (1Y)
-45.00%
Revenue / Employee
n/a
Profits / Employee
-$2,231,227
Market Cap
18.81M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
CLRB News
- 19 hours ago - Cellectar Biosciences Enters into Common Stock Agreements to Raise $2.5 Million Priced at Market Under Nasdaq Rules - GlobeNewsWire
- 1 day ago - Cellectar Granted U.S. FDA Breakthrough Therapy Designation for Iopofosine I 131 in Waldenstrom Macroglobulinemia (WM) - GlobeNewsWire
- 23 days ago - Cellectar Biosciences Inc. (CLRB) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Cellectar Biosciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 4 weeks ago - Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Tuesday, May 13, 2025 - GlobeNewsWire
- 5 weeks ago - Cellectar Announces Plan to Explore Strategic Alternatives - GlobeNewsWire
- 3 months ago - Cellectar Biosciences Inc. (CLRB) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Cellectar Biosciences Reports Financial Results for Year Ended 2024 and Provides a Corporate Update - GlobeNewsWire